| 000 | 00966 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517160036.0 | ||
| 264 | 0 | _c20170609 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMc1704012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKantarjian, Hagop | |
| 245 | 0 | 0 |
_aBlinatumomab for Acute Lymphoblastic Leukemia. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _c06 2017 |
||
| 300 |
_ae49 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntibodies, Bispecific _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 700 | 1 | _aJabbour, Elias | |
| 700 | 1 | _aTopp, Max S | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 376 _gno. 23 _gp. e49 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc1704012 _zAvailable from publisher's website |
| 999 |
_c27255592 _d27255592 |
||